$12.57
+1.03 (+8.93%)
Open$11.64
Previous Close$11.54
Day High$12.78
Day Low$11.64
52W High$3.16
52W Low$2.63
Volume—
Avg Volume756.5K
Market Cap118.38M
P/E Ratio20.39
EPS$0.15
SectorBiotechnology
Analyst Ratings
Hold
16 analysts
Price Target
-67.9% upside
Current
$12.57
$12.57
Target
$4.04
$4.04
$2.50
$4.04 avg
$4.74
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.81M | 16.40M | 15.17M |
| Net Income | -3,409,270 | -3,544,265 | -2,816,245 |
| Profit Margin | -21.6% | -21.6% | -18.6% |
| EBITDA | -3,096,571 | -3,398,004 | -2,964,187 |
| Free Cash Flow | -3,396,527 | -3,167,900 | -2,994,560 |
| Rev Growth | -2.4% | +19.8% | +8.3% |
| Debt/Equity | 0.33 | 0.37 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |